Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tfh2 and a subset of Tfh1 cells associate with antibody-mediated immunity to malaria
Megan S.F. Soon, Damian A. Oyong, Nicholas L. Dooley, Reena Mukhiya, Zuleima Pava, Dean W. Andrew, Jessica R. Loughland, James S. McCarthy, Jo-Anne Chan, James G. Beeson, Christian R. Engwerda, Ashraful Haque, Michelle J. Boyle
Megan S.F. Soon, Damian A. Oyong, Nicholas L. Dooley, Reena Mukhiya, Zuleima Pava, Dean W. Andrew, Jessica R. Loughland, James S. McCarthy, Jo-Anne Chan, James G. Beeson, Christian R. Engwerda, Ashraful Haque, Michelle J. Boyle
View: Text | PDF
Research Article Immunology Infectious disease

Tfh2 and a subset of Tfh1 cells associate with antibody-mediated immunity to malaria

  • Text
  • PDF
Abstract

High-affinity antibody production depends on CD4+ T follicular helper (Tfh) cells. In humans, peripheral blood Tfh cells are heterogenous, as evidenced by differential expression of the chemokine receptors CXCR3 and CCR6, which to date have served to classify 3 subsets, pTfh1, pTfh2, and pTfh17. Although pTfh1 responses dominate during blood-stage Plasmodium infections, a clear association with protective antibody responses remains to be described. We hypothesized that pTfh cells exhibit greater phenotypic and functional heterogeneity than described by CXCR3/CCR6 and that more nuanced pTfh subsets play distinct roles during Plasmodium infection. We mapped pTfh cell heterogeneity in healthy individuals prior to and during controlled human malaria infection (CHMI) using parallel single-cell RNA-Seq and VDJ-Seq. We uncovered 2 pTfh1 subsets or differential phenotypic states, distinguishable by CCR7 expression. Prior to infection, Tfh1-CCR7– cells exhibited higher baseline expression of inflammatory cytokines and genes associated with cytotoxicity. Tfh1-CCR7+ cells had higher germinal center signatures. Indeed, during CHMI, Tfh1-CCR7+, Tfh1-CCR7–, and Tfh2 cells all clonally expanded and became activated. However, only Tfh1-CCR7+ and Tfh2 cells positively associated with protective antibody production. Hence, our data reveal further complexity among human Tfh cells and highlight 2 distinct subsets associated with antibody-mediated immunity to malaria.

Authors

Megan S.F. Soon, Damian A. Oyong, Nicholas L. Dooley, Reena Mukhiya, Zuleima Pava, Dean W. Andrew, Jessica R. Loughland, James S. McCarthy, Jo-Anne Chan, James G. Beeson, Christian R. Engwerda, Ashraful Haque, Michelle J. Boyle

×

Figure 2

Phenotypic diversity of pTfh cell subsets based on CCR7 expression.

Options: View larger image (or click on image) Download as PowerPoint
Phenotypic diversity of pTfh cell subsets based on CCR7 expression.
A co...
A comprehensive spectral flow cytometry panel was used to analyze pTfh cells in healthy individuals (n = 19). (A) pTfh cells were identified by CXCR5 and PD-1 and analyzed with unbiased analysis of indicated markers. UMAP of a single experiment analyzing n = 7 individuals. Analysis performed 3 independent times. (B) Tfh cells were analyzed with manual gating. A gradient of CCR7 expression is detected within Tfh cells, and Tfh1-CCR7neg (CCR7–) and Tfh1-CCR7pos (CCR7+) subsets can be identified, along with Tfh2 and Tfh17 cells. (C) Proportion of Tfh subsets within total Tfh population. (D–I) Expression of cytotoxic markers NKG7 (D), granzyme K (E), and granzyme B (F) and transcriptional factors cMaf (G), SAP (H), and TIGIT (I) were analyzed within Tfh cell subsets. Flow plots are a representative individual with marker expression overlaid against CXCR3 and CCR6 or CCR7 and CD45RA. Box plots with median and IQR are indicated along with individuals. P is the paired Wilcoxon signed-rank test after adjustment with multiple-testing correction using Holm’s method, while the Kruskal-Wallis test is used for the global comparison. Only significant differences (P < 0.05) are shown. See also Supplemental Figures 3 and 4.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts